Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand
Completed
- Conditions
- Asthma
- Registration Number
- NCT00800241
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1020
Inclusion Criteria
- Established persistent asthma
- Currently treated with Symbicort SMART for 3 months or longer
Exclusion Criteria
- currently participating or have participated in a study with an investigational compound within the last 30 days
- current diagnosis of chronic obstructive pulmonary disease (COPD)
- smoked more than 10 pack-year
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of budesonide/formoterol use per patient On the survey date
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇹🇭Trang, Thailand